DxD Hub Webinar Series: Advancing Diagnostics - Digital Pathology Adoption and Impact in APAC

DxD Hub and KLAS Research are partnering to explore the rising relevance of digital pathology in the Asia-Pacific (APAC) region, where adoption is gaining traction amid growing demand for diagnostic innovation. Globally, digital pathology is still in its early stages, but interest is accelerating, driven by technological advances, emerging clinical use cases, and the need for greater diagnostic efficiency.

While the US and EU lead adoption, APAC faces unique challenges, including regulatory hurdles, reimbursement issues, limited funding, and infrastructure gaps. In this webinar, we’ll share data-driven insights on global trends, market penetration, and ROI, with a closer look at digital pathology in Singapore’s public healthcare system. Discover recent developments, clinical implementation efforts, workflow impact, and the key challenges faced by hospitals and healthcare clusters. Join us as we bridge global best practices with local realities to advance digital pathology across the region.

View the webinar report here: Digital Pathology Webinar Report

Chair and Moderator:

Mr. Lijoy George, Assistant Vice President, Head of Digital Health, DxD hub

Mr. Lijoy George is the Assistant Vice President and Head of Digital Health at DxD Hub. Before joining DxD Hub, he spent 16 years at Philips Singapore in roles including IT Business Partner, Transition and Adoption Manager for APAC, Senior Healthcare Project Manager for ASEAN, and Healthcare Operations Manager for ASEAN.

Speakers and Panelists:

Mr. Eder Lagemann, Regional Director, Europe & LATAM, KLAS Research

Mr. Eder Lagemann is an International Director at KLAS Research. He studied Electronics Technology and Business Management and has worked in various positions in the healthcare industry for the last 20 years. At KLAS, Eder works closely with key decision makers and influencers throughout the world to understand how vendors perform with the goal of sharing those findings back to the market.

A/Prof. Tan Soo Yong, Senior Consultant, Department of Pathology, NUHS and Research Director, AMPL&BPIS, IMCB

A/Prof. Tan Soo Yong is a Senior Consultant at the Department of Pathology, National University Hospital, and Associate Professor at the National University of Singapore. He also serves as Research Director at the Advanced Molecular Pathology Laboratory, IMCB, A*STAR; Visiting Consultant to the National Skin Centre; and Advisor to the Ministry of Health.

Prof. Weimiao Yu, Senior Principal Investigator, Bioinformatics Institute (BII), Head of Intelligent Digital and Molecular(IDMP) Lab

Prof. Weimiao Yu is a distinguished scientist in computational pathology, known for integrating AI and machine learning into biomedical imaging informatics. He is a Senior Principal Investigator at A*STAR, holding roles at IMCB and BII, and adjunct positions at NUS School of Medicine and NTU School of Biological Science. As co-founder of biotech firm A!maginostic Pte. Ltd., his combined industrial, academic, and entrepreneurial experience makes him a key figure in Singapore’s biomedical ecosystem.